Position in URGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$440,510
-$133,280 QoQ
Shares Held
24,500
0.0% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in URGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Palo Alto Investors LP holds $542,554,020 across 38 Biotechnology names. URGN ranks #36 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
415,269 | $67,904,786 | |
| 2 | ACAD |
Acadia Pharmaceuticals Inc
|
2,872,695 | $63,946,190 | |
| 3 | PTCT |
Ptc Therapeutics, Inc.
|
921,607 | $62,789,084 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
685,182 | $38,705,931 | |
| 5 | ANAB |
Anaptysbio, Inc
|
638,161 | $35,392,377 | |
| 6 | MIRM |
Mirum Pharmaceuticals, Inc.
|
325,175 | $30,039,666 | |
| 7 | DYN |
Dyne Therapeutics, Inc.
|
1,652,972 | $29,968,382 | |
| 8 | IRON |
Disc Medicine, Inc.
|
401,719 | $25,685,912 |
All Filings in URGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $440,510 | 24,500 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $573,790 | 24,500 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $488,775 | 24,500 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $335,650 | 24,500 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $270,970 | 24,500 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $260,925 | 24,500 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $311,150 | 24,500 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $411,110 | 24,500 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $367,500 | 24,500 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $367,500 | 24,500 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $343,245 | 24,500 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $253,575 | 24,500 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $226,380 | 24,500 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $217,315 | 24,500 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $203,840 | 24,500 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $200,655 | 24,500 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $213,395 | 24,500 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $232,995 | 24,500 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $412,090 | 24,500 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $374,115 | 24,500 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $477,260 | 24,500 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $441,490 | 24,500 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $472,605 | 24,500 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $639,940 | 24,500 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $437,080 | 24,500 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||